Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Delaware · 153rd General Assembly (2025-2026) · Bill

SB 361: AN ACT TO AMEND TITLE 29 OF THE DELAWARE CODE RELATING TO THE STATE EMPLOYEE BENEFITS COMMITTEE.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 361 is a bill introduced in the Delaware Senate on October 30, 2026. According to its official title, it concerns: AN ACT TO AMEND TITLE 29 OF THE DELAWARE CODE RELATING TO THE STATE EMPLOYEE BENEFITS COMMITTEE. Primary sponsor: Ray Seigfried (Democratic). Most recent recorded action (October 30, 2026): Introduced and Assigned to Executive Committee in Senate.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

This Act restructures the State Employee Benefits Committee into the State Employee Benefits Council and establishes 3 specialized working committees to assist the Council in managing contracted health services for State employees and eligible pensioners: the Clinical Evaluation Working Committee, the Policy and Planning Working Committee, and the Financial Evaluation Working Committee. This Act outlines the composition and statutory duties of each working committee to increase transparency, reduce costs, and improve the value of the State's health-care insurance plan. It grants all working committees the shared authority to establish quality metrics, enter into confidentiality agreements with pharmacy benefits managers, and request audits to determine the actual cost of pharmaceuticals to the State. Additionally, the Clinical Evaluation Working Committee is tasked with drafting health service agreements and managing the formulary. The Policy and Planning Working Committee is responsible for creating financial models using reference based pricing from Medicare reimbursement rates as a benchmark and requiring comprehensive financial disclosures from pharmacy benefits managers. The Financial Evaluation Working Committee is established to assess the financial implications of health policy and advise the Council. Finally, this Act mandates strict independence requirements for individuals or entities contracted to perform audits or reviews, establishes statutory definitions for key pharmacy pricing terms, and eliminates the Retiree Healthcare Benefits Advisory Subcommittee. This Act is effective January 1, 2028.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Ray SeigfriedPrimary sponsorDemocraticSenate5

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Introduced and Assigned to Executive Committee in Senate

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source